• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于改良鼻腔给药的辅料:近期进展的简要综述

Excipients Used for Modified Nasal Drug Delivery: A Mini-Review of the Recent Advances.

作者信息

Protopapa Chrystalla, Siamidi Angeliki, Pavlou Panagoula, Vlachou Marilena

机构信息

Department of Pharmacy, Section of Pharmaceutical Technology, School of Health Sciences, National and Kapodistrian University of Athens, 15784 Athens, Greece.

Department of Biomedical Sciences, Division of Aesthetics and Cosmetic Science, University of West Attica, 28 Ag. Spyridonos Str., 12243 Egaleo, Greece.

出版信息

Materials (Basel). 2022 Sep 21;15(19):6547. doi: 10.3390/ma15196547.

DOI:10.3390/ma15196547
PMID:36233902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9571052/
Abstract

The ongoing challenging task in the field of nasal drug delivery is the maintenance of an efficient concentration of the active substance in the target area for an adequate period of time. Thus, there is an urgent need to develop effective new strategies for drug delivery to the nose, using cutting edge technology and materials for this particular type of drug delivery. This review gives an account of the critical components of nasal drug delivery and the parameters influencing drug absorption in the nose, including the excipients required for modified drug administration.

摘要

鼻腔给药领域目前面临的一项具有挑战性的任务是,在足够长的时间内将活性物质在靶区域维持有效浓度。因此,迫切需要利用前沿技术和材料,开发用于鼻腔给药的有效新策略。本文综述了鼻腔给药的关键组成部分以及影响鼻腔药物吸收的参数,包括改良药物给药所需的辅料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f48/9571052/a1a2adb3efe0/materials-15-06547-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f48/9571052/a3195c48af17/materials-15-06547-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f48/9571052/479024ff548e/materials-15-06547-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f48/9571052/a1a2adb3efe0/materials-15-06547-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f48/9571052/a3195c48af17/materials-15-06547-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f48/9571052/479024ff548e/materials-15-06547-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f48/9571052/a1a2adb3efe0/materials-15-06547-g003.jpg

相似文献

1
Excipients Used for Modified Nasal Drug Delivery: A Mini-Review of the Recent Advances.用于改良鼻腔给药的辅料:近期进展的简要综述
Materials (Basel). 2022 Sep 21;15(19):6547. doi: 10.3390/ma15196547.
2
Recent Advances in the Excipients Used for Modified Ocular Drug Delivery.用于改良眼部药物递送的辅料的最新进展
Materials (Basel). 2021 Jul 31;14(15):4290. doi: 10.3390/ma14154290.
3
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery.刺激响应型原位凝胶鼻腔递药系统。
J Control Release. 2020 Nov 10;327:235-265. doi: 10.1016/j.jconrel.2020.07.044. Epub 2020 Jul 31.
4
The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery.壳聚糖纳米粒在鼻腔给药中的应用。
Mar Drugs. 2020 Nov 29;18(12):605. doi: 10.3390/md18120605.
5
Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.鼻腔给药制剂及药物传递系统中鼻腔制剂的评价
Ther Deliv. 2020 Mar;11(3):183-191. doi: 10.4155/tde-2019-0086. Epub 2020 Feb 12.
6
Insight on updates in polysaccharides for ocular drug delivery.眼部药物递送用多糖的最新研究进展
Carbohydr Polym. 2022 Dec 1;297:120014. doi: 10.1016/j.carbpol.2022.120014. Epub 2022 Aug 22.
7
Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies.载有氨磺必利的基于脂质的泊洛沙姆-结冷胶纳米乳凝胶的鼻脑给药:体内外药理学研究
Int J Pharm. 2021 Sep 25;607:121050. doi: 10.1016/j.ijpharm.2021.121050. Epub 2021 Aug 25.
8
Chitosan in nasal delivery systems for therapeutic drugs.壳聚糖在治疗性药物鼻内递药系统中的应用。
J Control Release. 2014 Sep 28;190:189-200. doi: 10.1016/j.jconrel.2014.05.003. Epub 2014 May 10.
9
Nasal delivery of insulin using bioadhesive chitosan gels.使用生物粘附性壳聚糖凝胶经鼻腔递送胰岛素。
Drug Deliv. 2006 Jan-Feb;13(1):31-8. doi: 10.1080/10717540500309040.
10
Improvement of Intranasal Drug Delivery with Intravail Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System.利用 Intravail 烷基糖苷赋形剂改善鼻腔内药物传递,作为一种黏膜吸收促进剂,辅助治疗中枢神经系统疾病。
Drugs R D. 2021 Dec;21(4):361-369. doi: 10.1007/s40268-021-00360-5. Epub 2021 Aug 25.

引用本文的文献

1
Quantification of Budesonide Retained in the Sinonasal Cavity After High-Volume Saline Irrigation in Post-Operative Chronic Rhinosinusitis.高容量盐水冲洗术后慢性鼻-鼻窦炎患者窦内布地奈德的定量研究。
Am J Rhinol Allergy. 2024 May;38(3):169-177. doi: 10.1177/19458924241237839. Epub 2024 Mar 8.
2
The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 2-Advanced Microfluidic Nasal In Vitro Model for Drug Absorption Testing.从鼻组织到芯片上鼻黏膜的路径:第2部分——用于药物吸收测试的先进微流控鼻体外模型。
Pharmaceutics. 2023 Oct 9;15(10):2439. doi: 10.3390/pharmaceutics15102439.
3
Development of Vinpocetine-Loaded Nasal Polymeric Micelles via Nano-Spray-Drying.

本文引用的文献

1
Aqueous Heat Method for the Preparation of Hybrid Lipid-Polymer Structures: From Preformulation Studies to Protein Delivery.用于制备脂质-聚合物杂化结构的水热法:从制剂前研究到蛋白质递送
Biomedicines. 2022 May 24;10(6):1228. doi: 10.3390/biomedicines10061228.
2
Different Methods and Formulations of Drugs and Vaccines for Nasal Administration.用于鼻腔给药的药物和疫苗的不同方法及制剂
Pharmaceutics. 2022 May 17;14(5):1073. doi: 10.3390/pharmaceutics14051073.
3
Silymarin/curcumin loaded albumin nanoparticles coated by chitosan as muco-inhalable delivery system observing anti-inflammatory and anti COVID-19 characterizations in oleic acid triggered lung injury and in vitro COVID-19 experiment.
通过纳米喷雾干燥法制备载长春西汀的鼻腔聚合物胶束
Pharmaceuticals (Basel). 2023 Oct 12;16(10):1447. doi: 10.3390/ph16101447.
4
Biomaterials-Enhanced Intranasal Delivery of Drugs as a Direct Route for Brain Targeting.生物材料增强型鼻腔内递药作为一种脑靶向的直接途径。
Int J Mol Sci. 2023 Feb 8;24(4):3390. doi: 10.3390/ijms24043390.
5
Thin film hydration versus modified spraying technique to fabricate intranasal spanlastic nanovesicles for rasagiline mesylate brain delivery: Characterization, statistical optimization, and in vivo pharmacokinetic evaluation.薄膜水化法与改良喷雾技术制备用于甲磺酸雷沙吉兰脑内传递的鼻腔可变形纳米囊泡:特征描述、统计优化和体内药代动力学评价。
Drug Deliv Transl Res. 2023 Apr;13(4):1153-1168. doi: 10.1007/s13346-022-01285-5. Epub 2022 Dec 30.
水飞蓟宾/姜黄素负载白蛋白纳米粒经壳聚糖包被作为黏液吸入式递药系统,观察其在油酸诱导的肺损伤和体外 COVID-19 实验中的抗炎和抗 COVID-19 特性。
Int J Biol Macromol. 2022 Feb 15;198:101-110. doi: 10.1016/j.ijbiomac.2021.12.073. Epub 2021 Dec 28.
4
Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles.载伏立康唑-丁香油传递体纳米粒的抗真菌原位鼻腔凝胶的制剂、优化及肾毒性评价。
Drug Deliv. 2021 Dec;28(1):2229-2240. doi: 10.1080/10717544.2021.1992040.
5
Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis.壳聚糖微粒鼻内免疫增强LACK-DNA疫苗的保护作用,并诱导针对内脏利什曼病的特异性持久免疫。
Microbes Infect. 2022 Mar;24(2):104884. doi: 10.1016/j.micinf.2021.104884. Epub 2021 Sep 3.
6
Progress in nasal drug delivery systems.鼻腔给药系统的研究进展。
Int J Pharm. 2021 Sep 25;607:120994. doi: 10.1016/j.ijpharm.2021.120994. Epub 2021 Aug 12.
7
T helper type 1 biased immune responses by PPE17 loaded core-shell alginate-chitosan nanoparticles after subcutaneous and intranasal administration.皮下和鼻内给药后,负载PPE17的核壳型海藻酸盐-壳聚糖纳米颗粒诱导1型辅助性T细胞偏向性免疫反应。
Life Sci. 2021 Oct 1;282:119806. doi: 10.1016/j.lfs.2021.119806. Epub 2021 Jul 9.
8
Feasibility of chitosan-based nanoparticles approach for intranasal immunisation of live attenuated Japanese encephalitis vaccine.壳聚糖纳米粒鼻内免疫减毒活日本脑炎疫苗的可行性研究。
Int J Biol Macromol. 2021 Jul 31;183:1096-1105. doi: 10.1016/j.ijbiomac.2021.05.050. Epub 2021 May 8.
9
The dry powder formulation of mixed cross-linked dextran microspheres and tetanus toxoid-loaded trimethyl chitosan nanospheres as a potent adjuvant for nasal delivery system.混合交联葡聚糖微球与负载破伤风类毒素的三甲基壳聚糖纳米球的干粉制剂作为鼻腔给药系统的有效佐剂。
Iran J Basic Med Sci. 2021 Jan;24(1):116-122. doi: 10.22038/ijbms.2020.49486.11313.
10
Characterization and Specification of a Trivalent Protein-Based Pneumococcal Vaccine Formulation Using an Adjuvant-Free Nanogel Nasal Delivery System.采用无佐剂纳米凝胶鼻内递送系统的三价蛋白基肺炎球菌疫苗制剂的特性描述和规格制定。
Mol Pharm. 2021 Apr 5;18(4):1582-1592. doi: 10.1021/acs.molpharmaceut.0c01003. Epub 2021 Feb 23.